Back to top
more

Teleflex (TFX)

(Delayed Data from NYSE)

$212.62 USD

212.62
410,337

+5.30 (2.56%)

Updated May 14, 2024 04:00 PM ET

After-Market: $212.67 +0.05 (0.02%) 6:50 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (99 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for TFX

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

0 items in cart

Teleflex Incorporated [TFX]

Reports for Purchase

Showing records 401 - 420 ( 463 total )

Company: Teleflex Incorporated

Industry: Medical - Instruments

Record: 401

08/03/2017

Company Report

Pages: 7

Solid Execution Aside, Not Too Surprised by the Guidance Raise

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: Teleflex Incorporated

Industry: Medical - Instruments

Record: 402

05/31/2017

Industry Report

Pages: 4

ANGO Has Nothing to Lose but Some Legal Fees; Sets Up TFX with a Win/Win

Provider: KEYBANC CAPITAL MARKETS

Price: 10.00

Research Provided by a Third Party

Company: Teleflex Incorporated

Industry: Medical - Instruments

Record: 403

05/30/2017

Company Report

Pages: 8

Takeaways from Investor Meetings

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: Teleflex Incorporated

Industry: Medical - Instruments

Record: 404

05/04/2017

Company Report

Pages: 7

Solid Quarter but Some Nitpicking Given the YTD Stock Performance

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: Teleflex Incorporated

Industry: Medical - Instruments

Record: 405

05/04/2017

Daily Note

Pages: 20

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Price: 50.00

Research Provided by a Third Party

Company: Teleflex Incorporated

Industry: Medical - Instruments

Record: 406

03/29/2017

Industry Report

Pages: 6

Takeaways from SAGES; Minimally Invasive Pathways to Growth for TFX - CNMD

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: Teleflex Incorporated

Industry: Medical - Instruments

Record: 407

02/23/2017

Daily Note

Pages: 3

Broader Recovery in CC Growth; Lower Gross Margin a Surprise

Provider: KEYBANC CAPITAL MARKETS

Price: 10.00

Research Provided by a Third Party

Company: Teleflex Incorporated

Industry: Medical - Instruments

Record: 408

02/23/2017

Company Report

Pages: 7

Valuation Likely Already Captures Much of the NT Optimism Following VASC

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: Teleflex Incorporated

Industry: Medical - Instruments

Record: 409

02/20/2017

Company Report

Pages: 9

Post VASC Close, Confident in Its DD Growth Drivers and 2018 Accretion Targets

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: Teleflex Incorporated

Industry: Medical - Instruments

Record: 410

01/17/2017

Daily Note

Pages: 8

Medical Technology: 4Q Preview; No Real Changes to Outlooks; Reducing Estimates Again for FX

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: Teleflex Incorporated

Industry: Medical - Instruments

Record: 411

12/02/2016

Daily Note

Pages: 3

Larger - More Expensive, but Consistent with Strategy of Acquiring Sales Growth - Gross Margin Accretive Targets

Provider: KEYBANC CAPITAL MARKETS

Price: 10.00

Research Provided by a Third Party

Company: Teleflex Incorporated

Industry: Medical - Instruments

Record: 412

12/02/2016

Daily Note

Pages: 12

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: Teleflex Incorporated

Industry: Medical - Instruments

Record: 413

11/20/2016

Industry Report

Pages: 5

Industry: Takeaways from AAGL

Provider: KEYBANC CAPITAL MARKETS

Price: 10.00

Research Provided by a Third Party

Company: Teleflex Incorporated

Industry: Medical - Instruments

Record: 414

10/28/2016

Company Report

Pages: 7

Growth and Margin Expectations Appear More Muted NT; Lowering Estimates

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: Teleflex Incorporated

Industry: Medical - Instruments

Record: 415

10/27/2016

Daily Note

Pages: 3

Reduced Sales Guidance and Changes to Restructuring Actions Likely to Offset EPS Positives

Provider: KEYBANC CAPITAL MARKETS

Price: 10.00

Research Provided by a Third Party

Company: Teleflex Incorporated

Industry: Medical - Instruments

Record: 416

07/31/2016

Company Report

Pages: 7

Benefits of Gross Margin Initiatives Evident and Driving EPS Leverage

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: Teleflex Incorporated

Industry: Medical - Instruments

Record: 417

07/28/2016

Daily Note

Pages: 3

Similar to Peers, Solid Quarter and Modest Bump to EPS Guidance

Provider: KEYBANC CAPITAL MARKETS

Price: 10.00

Research Provided by a Third Party

Company: Teleflex Incorporated

Industry: Medical - Instruments

Record: 418

07/28/2016

Daily Note

Pages: 26

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Price: 75.00

Research Provided by a Third Party

Company: Teleflex Incorporated

Industry: Medical - Instruments

Record: 419

07/12/2016

Daily Note

Pages: 16

Morning Meeting Notes

Provider: KEYBANC CAPITAL MARKETS

Price: 50.00

Research Provided by a Third Party

Company: Teleflex Incorporated

Industry: Medical - Instruments

Record: 420

07/12/2016

Company Report

Pages: 8

Valuation Still Matters; Downgrade to SW

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party